➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Medtronic
McKinsey
Merck
Mallinckrodt

Last Updated: June 23, 2021

DrugPatentWatch Database Preview

Nanjing King-friend Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for NANJING KING-FRIEND, and what generic and branded alternatives to NANJING KING-FRIEND drugs are available?

NANJING KING-FRIEND has six approved drugs.



Summary for Nanjing King-friend
US Patents:0
Tradenames:3
Ingredients:2
NDAs:6

Drugs and US Patents for Nanjing King-friend

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nanjing King-friend ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 206834-006 Nov 29, 2019 AP RX No No   Get Started Free   Get Started Free
Nanjing King-friend HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 212061-001 Jul 15, 2020 AP RX No No   Get Started Free   Get Started Free
Nanjing King-friend ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 206834-007 Nov 29, 2019 AP RX No No   Get Started Free   Get Started Free
Nanjing King-friend HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 211005-001 Dec 14, 2018 AP RX No No   Get Started Free   Get Started Free
Nanjing King-friend HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 211004-001 Feb 24, 2020 AP RX No No   Get Started Free   Get Started Free
Nanjing King-friend ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 206834-003 Nov 29, 2019 AP RX No No   Get Started Free   Get Started Free
Nanjing King-friend HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 211007-002 May 28, 2019 AP RX No No   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
AstraZeneca
Express Scripts
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.